Attached files
| file | filename |
|---|---|
| EX-5.1 - EX-5.1 - Sensei Biotherapeutics, Inc. | d126514dex51.htm |
| S-1MEF - S-1MEF - Sensei Biotherapeutics, Inc. | d126514ds1mef.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on Form S-1 of our report dated November 12, 2020 (February 1, 2021 as to the effects of the reverse stock split discussed in Note 15) relating to the financial statements of Sensei Biotherapeutics, Inc. appearing in the Registration Statement No. 333-252138 on Form S-1. We also consent to the reference to us under the heading “Experts” in Registration Statement No 333-252138 on Form S-1.
/s/ Deloitte & Touche LLP
Baltimore, Maryland
February 3, 2021